Virginia Hernández–Gea

Beyond the class effect: Rethinking anticoagulation in liver disease

The use of direct oral anticoagulants (DOACs) has transformed hepatology. Initially introduced as an alternative to vitamin K antagonists and low-molecular-weight heparin for portal vein thrombosis (PVT), DOACs are now increasingly used across the spectrum of vascular liver disea...